AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

PRevention of OsTEoporotiC FracTure 2 Pilot Study

RecruitingNAAges 50 Years - anyAllThird Affiliated Hospital, Sun Yat-Sen University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

With the aging of the world population, osteoporosis and fragility fractures have become global public health concerns. It has been estimated the population of people โ‰ฅ60 years of age will increase from 229 million (16.2%) in 2017 to 479 million (35.1%) by 2050 in China. Because age is an important predictor of osteoporosis and fragility fracture, the incidence of fragility fracture has increased dramatically in China over the past decades. Timely treatment of osteoporosis is an effective way to decrease additional fracture risk among patients with fragility fractures, but anti-osteoporosis treatment rate is relatively low in China. Effective fracture prevention intervention is urgently needed in China. As a potential way to achieve effective risk communication, shared decision-making allows patients to be active participants in the management of osteoporosis. The investigators designed

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Local residents (live in the city where the hospital is located for half a year or more); 2. Hospitalized patients with fractures aged 50 years and above; 3. First fracture, without history of fracture; 4. Never diagnosed as "osteoporosis" before admission; 5. No fracture history, and never receive any bone mineral density test, and never take anti-osteoporosis medication in the 4 years before admission; 6. Hospitalized patients with the following fractures: hip fracture, thoracic spine fracture, and lumbar spine fracture; 7. New fragility fracture: fracture that occurs after minor trauma or daily activities, such as a fracture caused by a fall from standing height or less; fracture happened within 6 weeks; 8. Not living in a nursing or rehabilitation institution before fracture; 9. Possess reading ability, and can read and understand informed consent forms or medical materials independently. Exclusion Criteria: 1. Patients with pathological fractures caused by tumor or infection; 2. Patients with cognitive dysfunction or mental disorder; 3. AIDS patients; 4. Patients who refuse to follow-up, or have poor compliance for follow-up, or fail to understand and cooperate for follow-up; 5. Hearing or visual impairment, and unable to communicate or read materials; 6. Patients who have participate in other studies; 7. Other conditions that the investigator considered inappropriate to enroll.
๐Ÿ’Š

What it tests

  • Multifaceted Intervention
๐Ÿ“

Where

7 sites
The Second Affiliated Hospital of Hunan University of Chinese Medicine
Changsha, China
Dongguan Eighth People's Hospital
Dongguan, China
Third Affiliated Hospital, Sun Yat-sen University
Guangzhou, China
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, China
The First People's Hospital of Hefei
Hefei, China
Longgang Orthopedics Hospital of Shenzhen
Shenzhen, China
The Third People's Hospital of Longgang District Shenzhen
Shenzhen, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy